Keywords
Multiple Myeloma ×
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

- 6/8/15 - 1 form, 9 itemgroups, 46 items, 1 language
Itemgroups: ECOG clinical trial administrative data, Reporting Period, Section II - E1A05 QOL Assessment Not Completed, Indicate reason(s) why form was not completed, Section III Assessment Completed, How was the patient assisted?, What was the reason for assistance?, Who assisted or completed assessment?, Comments
- 6/9/15 - 1 form, 9 itemgroups, 30 items, 1 language
Itemgroups: Header, Disease Status, Treatment, Treatment, Treatment, Dose Modification, Physical: Start Date of Treatment, STEM CELL COLLECTION, Comments
- 6/8/15 - 1 form, 11 itemgroups, 49 items, 1 language
Itemgroups: Patient demographics, ECOG clinical trial administrative data, Data amendment, On Treatment Reporting Period, Reporting Period, Vital Status, Patient Characteristics, Therapy Administered - Section I, Therapy Administered, Non-Protocol Therapy, Footer Module
- 6/8/15 - 1 form, 15 itemgroups, 80 items, 1 language
Itemgroups: ECOG clinical trial administrative data, Patient demographics, Reporting period, Section I, Indicate reason(s) why form was not completed - E4A08 Quality of Life Form, Section III Assessment Completed - E4A08 Quality of Life Form, How was the patient assisted - E4A08 Quality of Life Form, What was the reason for assistance - E4A08 Quality of Life Form, Who assisted or completed assessment - E4A08 Quality of Life Form, Indicate reason(s) why form was not completed - E4A08 FACT Neurotoxicity Form, Section III Assessment Completed - E4A08 FACT Neurotoxicity Form, How was the patient assisted - E4A08 FACT Neurotoxicity Form, What was the reason for assistance - E4A08 FACT Neurotoxicity Form, Who assisted or completed assessment - E4A08 FACT Neurotoxicity Form, Comments